Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 04 10 2021
accepted: 13 01 2022
revised: 22 12 2021
pubmed: 8 3 2022
medline: 24 6 2022
entrez: 7 3 2022
Statut: ppublish

Résumé

To identify the main problem areas in the applicability of the current TNM staging system (8 A global case-based online survey was conducted including 41 image-based rectal cancer cases focusing on various items included in the TNM system. Cases reaching < 80% agreement among survey respondents were identified as problem areas and discussed among an international expert panel, including 5 radiologists, 6 colorectal surgeons, 4 radiation oncologists, and 3 pathologists. Three hundred twenty-one respondents (from 32 countries) completed the survey. Sixteen problem areas were identified, related to cT staging in low-rectal cancers, definitions for cT4b and cM1a disease, definitions for mesorectal fascia (MRF) involvement, evaluation of lymph nodes versus tumor deposits, and staging of lateral lymph nodes. The expert panel recommended strategies on how to handle these, including advice on cT-stage categorization in case of involvement of different layers of the anal canal, specifications on which structures to include in the definition of cT4b disease, how to define MRF involvement by the primary tumor and other tumor-bearing structures, how to differentiate and report lymph nodes and tumor deposits on MRI, and how to anatomically localize and stage lateral lymph nodes. The recommendations derived from this global survey and expert panel discussion may serve as a practice guide and support tool for radiologists (and other clinicians) involved in the staging of rectal cancer and may contribute to improved consistency in radiological staging and reporting. • Via a case-based online survey (incl. 321 respondents from 32 countries), we identified 16 problem areas related to the applicability of the TNM staging system for the radiological staging and reporting of rectal cancer. • A multidisciplinary panel of experts recommended strategies on how to handle these problem areas, including advice on cT-stage categorization in case of involvement of different layers of the anal canal, specifications on which structures to include in the definition of cT4b disease, how to define mesorectal fascia involvement by the primary tumor and other tumor-bearing structures, how to differentiate and report lymph nodes and tumor deposits on MRI, and how to anatomically localize and stage lateral lymph nodes. • These recommendations may serve as a practice guide and support tool for radiologists (and other clinicians) involved in the staging of rectal cancer and may contribute to improved consistency in radiological staging and reporting.

Identifiants

pubmed: 35254485
doi: 10.1007/s00330-022-08591-z
pii: 10.1007/s00330-022-08591-z
pmc: PMC9213337
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4991-5003

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Gollub MJ, Lall C, Lalwani N, Rosenthal MH (2019) Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI. Abdom Radiol (NY) 44(11):3549–3558
doi: 10.1007/s00261-019-01996-3
Jessup MJ, Goldberg RM, Asare EA, et al (2017) Colon and rectum. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al Eds. AJCC cancer staging manual (8th edition). Springer: 251–273
Wittekind C, Greene FL, Henson DE, et al (2003) Explanatory notes specific anatomical sites. In: Wittekind Ch, Greene F.L, Henson D.E et al eds. TNM supplement: a commentary on uniform use 3
Wittekind C, Brierly JD, Lee AWM, et al (2019) Explanatory notes specific anatomical sites. In: Wittekind C, Brierly J.D, Lee A.W.M, et al eds. TNM supplement: a commentary on uniform use. 5
Shihab OC, How P, West N et al (2011) Can a novel MRI staging system for low rectal cancer aid surgical planning? Dis Colon Rectum 54(10):1260–1264
doi: 10.1097/DCR.0b013e31822abd78
Bamba Y, Itabashi M, Kameoka S (2012) Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection. Surg Today 42(4):328–333
doi: 10.1007/s00595-011-0007-6
You YN, Hardiman KM, Bafford A et al (2020) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum 63(9):1191–1222
doi: 10.1097/DCR.0000000000001762
Bleday R, Melnitchouk N (2014) Surgical management of rectal cancer. In: Beck, D.E., Nasseri, Y., Hull, et al eds. The ASCRS manual of colon and rectal surgery (2
Valentini V, Gambacorta MA, Barbaro B et al (2016) International consensus guidelines on clinical target volume delineation in rectal cancer. Radiother Oncol 120(2):195–201
doi: 10.1016/j.radonc.2016.07.017
Glimelius B, Beets-Tan R, Blomqvist L et al (2011) Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol 29(16):2142–2143
doi: 10.1200/JCO.2010.34.4473
Glynne-Jones R, Wyrwicz L, Tiret E, et al (2017) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv22–iv40
National Comprehensive Cancer Network. Rectal cancer (version 1.2021) [ www.nccn.org ] Available at: https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf . Accessed June 21, 2021
Federatie Medische specialisten. Richtlijn colorectaal carcinoom (2019 update). Available at: https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/startpagina_-_crc.html . Accessed December 2, 2020
Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH, Pathology Review Committee; Cooperative Clinical Investigators (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26(3):350–357
doi: 10.1097/00000478-200203000-00009
Beets-Tan RGH, Lambregts DMJ, Maas M et al (2019) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4):1465–1475
doi: 10.1007/s00330-017-5026-2
Shihab OC, Quirke P, Heald RJ, Moran BJ, Brown G (2010) Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 97(9):1431–1436
doi: 10.1002/bjs.7116
Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235(4):449–457
doi: 10.1097/00000658-200204000-00001
Bipat S, Glas AS, Slors FJ et al (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging—a meta-analysis. Radiology 232(3):773–783
doi: 10.1148/radiol.2323031368
Lahaye MJ, Engelen SM, Nelemans PJ et al (2005) Imaging for -predicting the risk factors—the circumferential resection margin and nodal disease—of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 26(4):259–268
doi: 10.1053/j.sult.2005.04.005
Fleming ID, Cooper JS, Henson DE, et al (1997) Eds. General information on cancer staging and end-results reporting. In: AJCC Cancer Staging Manual (5
Greene FL, Page DL, Fleming ID, et al (2002). Eds. AJCC cancer staging manual (6
Nagtegaal ID, Knijn N, Hugen N et al (2017) Tumour deposits in colorectal cancer: improving the value of modern staging-a systematic review and meta-analysis. J Clin Oncol 35(10):1119–1127
doi: 10.1200/JCO.2016.68.9091
Lord A, Brown G, Abulafi M et al (2021) Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus study. Histopathology 79(2):168–175
doi: 10.1111/his.14344
Lord AC, Moran B, Abulafi M et al (2020) Can extranodal tumour deposits be diagnosed on MRI? Protocol for a multicentre clinical trial (the COMET trial). BMJ Open 10(10):e033395. https://doi.org/10.1136/bmjopen-2019-033395
doi: 10.1136/bmjopen-2019-033395 pubmed: 33033006 pmcid: 7542933
Schaap DP, Boogerd LSF, Konishi T et al (2021) Lateral node study consortium. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg 108(2):205–213
doi: 10.1093/bjs/znaa009
Ogura A, Konishi T, Cunningham C et al (2019) Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 154(9):e192172. https://doi.org/10.1001/jamasurg.2019.2172
Ogura A, Konishi T, Cunningham C, et al Lateral Node Study Consortium (2019) Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 37(1):33–43
D’Souza N, de Neree Tot Babberich MPM, d’Hoore A et al (2019) Definition of the rectum: an international, expert-based delphi consensus. Ann Surg 270(6):955–959
doi: 10.1097/SLA.0000000000003251
Bogveradze N, Lambregts DMJ, El Khababi N et al (2021) The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: reproducibility, pitfalls and potential impact on treatment stratification. Eur J Surg Oncol 20:S0748-7983(21)00735–6. https://doi.org/10.1016/j.ejso.2021.09.009
Gollub MJ, Maas M, Weiser M et al (2013) Recognition of the anterior peritoneal reflection at rectal MRI. AJR Am J Roentgenol 200(1):97–101
doi: 10.2214/AJR.11.7602

Auteurs

Doenja M J Lambregts (DMJ)

Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. d.lambregts@nki.nl.

Nino Bogveradze (N)

Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Department of Radiology, American Hospital Tbilisi, Tbilisi, Georgia.

Lennart K Blomqvist (LK)

Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.

Emmanouil Fokas (E)

Department of Radiooncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
Frankfurt Cancer Institute (FCI), University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.

Julio Garcia-Aguilar (J)

Department of Surgery, Colorectal Service, Benno C. Schmidt Chair in Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Bengt Glimelius (B)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Marc J Gollub (MJ)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Tsuyoshi Konishi (T)

Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Corrie A M Marijnen (CAM)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.

Iris D Nagtegaal (ID)

Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Per J Nilsson (PJ)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Division of Coloproctology, Pelvic Cancer Center, Karolinska University Hospital, Stockholm, Sweden.

Rodrigo O Perez (RO)

Hospital Alemão Oswaldo Cruz & Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil.

Petur Snaebjornsson (P)

Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Stuart A Taylor (SA)

Centre for Medical Imaging, University College London Hospital, London, UK.

Damian J M Tolan (DJM)

Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Vincenzo Valentini (V)

Department of Bioimaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica S. Cuore, Rome, Italy.

Nicholas P West (NP)

Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.

Albert Wolthuis (A)

Department of Abdominal Surgery, University Hospitals Leuven, Leuven, Belgium.

Max J Lahaye (MJ)

Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.

Monique Maas (M)

Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.

Geerard L Beets (GL)

GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Regina G H Beets-Tan (RGH)

Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. r.beetstan@nki.nl.
GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. r.beetstan@nki.nl.
Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark. r.beetstan@nki.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH